Skip to content
The Policy VaultThe Policy Vault

Cayston — Highmark

cystic fibrosis (CF) with Pseudomonas aeruginosa colonization

Initial criteria

  • Diagnosis of cystic fibrosis (ICD-10: E84)
  • Member is colonized with Pseudomonas aeruginosa

Reauthorization criteria

  • Prescriber attests that the member experienced a decrease in sputum density of Pseudomonas aeruginosa
  • OR prescriber attests that the member experienced an increase in FEV1
  • OR prescriber attests that the member experienced a decrease in the number of hospitalizations
  • OR prescriber attests that the member experienced a decrease in the number of pulmonary exacerbations

Approval duration

up to 24 months